In our study, there were significant reductions in COX-2 expression in the surface epithelium (p = 0.007) and stromal cells (p < 0.001) in pterygium tissue post-intralesional injection of ranibizumab as compared to the control group. This evidence concerns the gene PTGS2 and pterygium.